Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new deal for copay caps on Eli Lilly (LLY) and Novo Nordisk (NVO) weight loss ...

Cigna is rolling out another weight-loss drug initiative to bolster access to the popular medications and tap more deeply into the booming market. The company's Evernorth Health Services ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy ... Zepbound. The monthly copay for GLP-1 weight loss medicines will be limited to no more than $200 under the new ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced Wednesday ...

Evernorth — the Cigna division that oversees the Express Scripts pharmacy benefit manager business — has added an option that can help employers cap the monthly copays for two popular weight ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

While Cigna would not discuss the actual discounts reached under the new Evernorth arrangement, analysts say large employers and other insurers have gotten between 30% to 50% below the drugs' list ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company's pharmacy benefits unit Evernorth ...